NanoVibronix (NanoVibronix) Days Sales Outstanding

: 13.57 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

NanoVibronix's average Accounts Receivable for the three months ended in Dec. 2023 was $0.18 Mil. NanoVibronix's Revenue for the three months ended in Dec. 2023 was $1.18 Mil. Hence, NanoVibronix's Days Sales Outstanding for the three months ended in Dec. 2023 was 13.57.

The historical rank and industry rank for NanoVibronix's Days Sales Outstanding or its related term are showing as below:

NAOV' s Days Sales Outstanding Range Over the Past 10 Years
Min: 8.77 Med: 31.43 Max: 70.93
Current: 15.6

During the past 13 years, NanoVibronix's highest Days Sales Outstanding was 70.93. The lowest was 8.77. And the median was 31.43.

NAOV's Days Sales Outstanding is ranked better than
96.03% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 63.7 vs NAOV: 15.60

NanoVibronix's Days Sales Outstanding increased from Dec. 2022 (0.00) to Dec. 2023 (13.57).

NanoVibronix Days Sales Outstanding Historical Data

The historical data trend for NanoVibronix's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NanoVibronix Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

70.93

39.84

24.23

50.72

26.14

NanoVibronix Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding																-	8.64	20.02	10.26	13.57

Competitive Comparison

For the Medical Devices subindustry, NanoVibronix's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NanoVibronix Days Sales Outstanding Distribution

For the Medical Devices & Instruments industry and Healthcare sector, NanoVibronix's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where NanoVibronix's Days Sales Outstanding falls into.

NanoVibronix Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

NanoVibronix's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.009	+	0.318)	/	2 )	/	2.283	*	365
=	0.1635					/	2.283	*	365
=	26.14

NanoVibronix's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.032	+	0.318)	/	2 )	/	1.177	*	365 / 4
=	0.175					/	1.177	*	365 / 4
=	13.57

NanoVibronix (NAS:NAOV) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

NanoVibronix Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of NanoVibronix's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

NanoVibronix (NanoVibronix) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NanoVibronix Inc (NAS:NAOV) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

56R0:Germany

Address

525 Executive Boulevard, Elmsford, New York, NY, USA, 10523

Website

https://www.nanovibronix.com

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.

Executives

Christopher M Fashek	director	8023 VANTAGE DR, SAN ANTONIO TX 78230
Stephen Russell Brown	officer: Chief Financial Officer	18-B NEIL COURT, OCEANSIDE NY 11572
Aurora Cassirer	director	C/O NANOVIBRONIX, INC.,, 525 EXECUTIVE BOULEVARD, ELMSFORD NY 10523
Maria Schroeder	director	C/O NANOVIBRONIX, INC.,, 525 EXECUTIVE BOULEVARD, ELMSFORD NY 10523
Brian M Murphy	director, officer: Chief Executive Officer	525 EXECUTIVE BOULEVARD, ELMSFORD NY 10523
Michael Ferguson	director	525 EXECUTIVE BOULEVARD, ELMSFORD NY 10523
Thomas Mika	director	TEGAL CORP, 2201 SOUTH MCDOWELL BLVD, PETALUMA CA 94954
Ira A Greenstein	director	IDT CORP, 520 BROAD STREET, NEWARK NJ 07102
Harold Jacob	director, officer: Chief Medical Officer	HAADMUR MEBUYON 26, HARNOT, JERUSALEM L3 95403
Martin M Goldstein	director	C/O NANOVIBRONIX, INC., 525 EXECUTIVE BOULEVARD, ELMSFORD NY 10523
William Stern	director, officer: Chief Executive Officer	525 EXECUTIVE BOULEVARD, ELMSFORD NY 10523
Jona Zumeris	director, officer: VP of Technology	105 MAXESS ROAD, SUITE S124, MELVILLE NY 11747
Miriam W Kelly	10 percent owner	P.O. BOX 1443, BROOKLANDVILLE MD 21022